Altered p53 regulation of MIR-148b and p55PIK contributes to tumor progression in colorectal cancer

Oncogene

Volumn 34, Issue 7, 2015, Pages 912-921

  Wang, G ^a   Cao, X ^a   Lai, S ^a   Luo, X ^a   Feng, Y ^a   Wu, J ^a   Ning, Q ^b   Xia, X ^a   Wang, J ^b   Gong, J ^a   Hu, J ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MICRORNA; MICRORNA 148B; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSOTOL 3 KINASE P55PIK; PROTEIN P53; UNCLASSIFIED DRUG; MIRN148 MICRORNA, HUMAN; PIK3R3 PROTEIN, HUMAN; RNA; TP53 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DNA SYNTHESIS; GENETIC TRANSFECTION; HCT116 CELL LINE; HUMAN; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN RNA BINDING; REGULATORY MECHANISM; RNA INTERFERENCE; TRANSCRIPTION REGULATION; TUMOR GROWTH; TUMOR VOLUME; BIOSYNTHESIS; CACO 2 CELL LINE; CLINICAL TRIAL; COLORECTAL TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; MALE; METABOLISM; PATHOLOGY;

CACO-2 CELLS; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MALE; MICRORNAS; PHOSPHATIDYLINOSITOL 3-KINASES; RNA, NEOPLASM; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84927171296     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.30     Document Type: Article

References (29)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
2. Gregory RI, Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res. 2005;65:3509-3512.
3. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005;122:6-7.
4. De Santa F, Iosue I, Del Rio A, Fazi F. microRNA biogenesis pathway as a therapeutic target for human disease and cancer. Curr Pharm Des 2013;19:745-764.
5. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 2006;103:2257-2261.
6. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. MicroRNA expression profiles classify human cancers. Nature 2005;435:834-838.
7. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009;58:1375-1381.
8. Chang H, Zhou X, Wang ZN, Song YX, Zhao F, Gao P et al. Increased expression of miR-148b in ovarian carcinoma and its clinical significance. Mol Med Rep 2012;5:1277-1280.
9. Nymark P, Guled M, Borze I, Faisal A, Lahti L, Salmenkivi K et al. Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histologyrelated changes in lung cancer. Genes Chromosomes Cancer 2011;50:585-597.
10. Song Y, Xu Y, Wang Z, Chen Y, Yue Z, Gao P et al. MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer. Int J Cancer 2012;131:1042-1051.
11. Szafranska AE, Davison TS, John J, Cannon T, Sipos B, Maghnouj A et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007;26:4442-4452.
12. Song YX, Yue ZY, Wang ZN, Xu YY, Luo Y, Xu HM et al. MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. Mol Cancer 2011;10:1.
13. Pons S, Asano T, Glasheen E, Miralpeix M, Zhang Y, Fisher TL et al. The structure and function of p55PIK reveal a new regulatory subunit for phosphatidylinositol 3-kinase. Mol Cell Biol 1995;15:4453-4465.
14. Zhang L, Huang J, Yang N, Greshock J, Liang S, Hasegawa K et al. Integrative genomic analysis of phosphatidylinositol 3'-kinase family identifies PIK3R3 as a potential therapeutic target in epithelial ovarian cancer. Clin Cancer Res 2007;13:5314-5321.
15. Zhou J, Chen GB, Tang YC, Sinha RA, Wu Y, Yap CS et al. Genetic and bioinformatic analyses of the expression and function of PI3K regulatory subunit PIK3R3 in an Asian patient gastric cancer library. BMC Med Genomics 2012;5:34.
16. Hu J, Xia X, Cheng A, Wang G, Luo X, Reed MF et al. A peptide inhibitor derived from p55PIK phosphatidylinositol 3-kinase regulatory subunit: a novel cancer therapy. Mol Cancer Ther 2008;7:3719-3728.
17. Hu J, Liu S, Wang J, Luo X, Gao X, Xia X et al. Overexpression of the N-terminal end of the p55gamma regulatory subunit of phosphatidylinositol 3-kinase blocks cell cycle progression in gastric carcinoma cells. Int J Oncol 2005;26:1321-1327.
18. Xia X, Cheng A, Akinmade D, Hamburger AW. The N-terminal 24 amino acids of the p55 gamma regulatory subunit of phosphoinositide 3-kinase binds Rb and induces cell cycle arrest. Mol Cell Biol 2003;23:1717-1725.
19. Wang G, Deng Y, Cao X, Lai S, Tong Y, Luo X et al. Blocking p55PIK signaling inhibits proliferation and induces differentiation of leukemia cells. Cell Death Differ 2012;19:1870-1879.
20. Wang G, Chen C, Yang R, Cao X, Lai S, Luo X et al. p55PIK-PI3K stimulates angiogenesis in colorectal cancer cell by activating NF-kappaB pathway. Angiogenesis 2013;16:561-573.
21. Muller PA, Vousden KH. p53 mutations in cancer. Nat Cell Biol. 2013;15:2-8.
22. He L, He X, Lim LP, De Stanchina E, Xuan Z, Liang Y et al. A microRNA component of the p53 tumour suppressor network. Nature 2007;447:1130-1134.
23. Hermeking H. MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer 2012;12:613-626.
24. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007;26:745-752.
25. Kim NH, Kim HS, Li XY, Lee I, Choi HS, Kang SE et al. A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. J Cell Biol 2011;195:417-433.
26. Chang CJ, Chao CH, Xia W, Yang JY, Xiong Y, Li CW et al. p53 regulates epithelialmesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol 2011;13:317-323.
27. Kim T, Veronese A, Pichiorri F, Lee TJ, Jeon YJ, Volinia S et al. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med 2011;208:875-883.
28. Zhao G, Zhang JG, Liu Y, Qin Q, Wang B, Tian K et al. miR-148b functions as a tumor suppressor in pancreatic cancer by targeting AMPKalpha1. Mol Cancer Ther 2013;12:83-93.
29. Russo A, Bazan V, Iacopetta B, Kerr D, Soussi T, Gebbia N et al. The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment. J Clin Oncol 2005;23:7518-7528.